Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


13.02.2017

1 Acta Oncol
1 Am J Health Syst Pharm
1 Ann Hematol
2 Anticancer Res
1 Biol Pharm Bull
1 BMJ Case Rep
1 Cancer Biother Radiopharm
1 Cancer Sci
1 Cell Death Dis
1 Clin Biochem
1 Clin Epigenetics
1 Clin Genitourin Cancer
2 Clin Lab
1 Cureus
2 Diagn Cytopathol
1 Diagn Microbiol Infect Dis
1 Drug Dev Res
2 Eur Radiol
1 Eur Urol Focus
1 Front Physiol
1 G Chir
1 Int J Mol Sci
1 J Cancer Res Clin Oncol
1 J Surg Oncol
3 Medicine (Baltimore)
2 Nurse Pract
4 Oncotarget
1 Radiol Clin North Am
1 Transl Oncol
2 Tumour Biol
1 Urologia
1 Urology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Oncol

  1. NOLAN CP, Forde EJ
    A review of the use of fiducial markers for image-guided bladder radiotherapy.
    Acta Oncol. 2016;55:533-8.
    PubMed     Text format     Abstract available


    Am J Health Syst Pharm

  2. KURTZHALTS K, Gee ME, Feuz L, Krajewski KC, et al
    Evidence of a clinically significant interaction between warfarin and intravesical gemcitabine.
    Am J Health Syst Pharm. 2016;73:1508-11.
    PubMed     Text format     Abstract available


    Ann Hematol

  3. KIM TK, Xu ML, Podoltsev NA, Prebet T, et al
    Single agent blinatumumab as frontline therapy for an 85-year-old patient with B cell precursor acute lymphoblastic leukemia.
    Ann Hematol. 2016.
    PubMed     Text format    


    Anticancer Res

  4. IWAMOTO H, Izumi K, Shimura Y, Natsagdorj A, et al
    Metastasectomy Improves Survival in Patients with Metastatic Urothelial Carcinoma.
    Anticancer Res. 2016;36:5557-5561.
    PubMed     Text format     Abstract available

  5. WIECZOREK E, Jablonowski Z, Tomasik B, Gromadzinska J, et al
    Different Gene Expression and Activity Pattern of Antioxidant Enzymes in Bladder Cancer.
    Anticancer Res. 2017;37:841-848.
    PubMed     Text format     Abstract available


    Biol Pharm Bull

  6. NAKAMURA T, Noma Y, Sakurai Y, Harashima H, et al
    Modifying Cationic Liposomes with Cholesteryl-PEG Prevents Their Aggregation in Human Urine and Enhances Cellular Uptake by Bladder Cancer Cells.
    Biol Pharm Bull. 2017;40:234-237.
    PubMed     Text format     Abstract available


    BMJ Case Rep

  7. GOLDMAN H, Sowter S
    Urachal adenocarcinoma incidentally discovered in a young woman at elective caesarean section.
    BMJ Case Rep. 2016;2016.
    PubMed     Text format     Abstract available


    Cancer Biother Radiopharm

  8. LI X, Liu S
    Suppression of HBXIP Reduces Cell Proliferation, Migration and Invasion In Vitro, and Tumorigenesis In Vivo in Human Urothelial Carcinoma of the Bladder.
    Cancer Biother Radiopharm. 2016;31:311-316.
    PubMed     Text format     Abstract available


    Cancer Sci

  9. SHEN KH, Li CF, Chien LH, Huang CH, et al
    Role of galectin-1 in urinary bladder urothelial carcinoma cell invasion through the JNK pathway.
    Cancer Sci. 2016;107:1390-1398.
    PubMed     Text format     Abstract available


    Cell Death Dis

  10. HUI K, Gao Y, Huang J, Xu S, et al
    RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial-mesenchymal transition via MAPK/SOX2 pathway in bladder cancer.
    Cell Death Dis. 2017;8:e2600.
    PubMed     Text format     Abstract available


    Clin Biochem

  11. DE ALMEIDA EF, Abdalla TE, Arrym TP, de Oliveira Delgado P, et al
    Plasma and urine DNA levels are related to microscopic hematuria in patients with bladder urothelial carcinoma.
    Clin Biochem. 2016;49.
    PubMed     Text format     Abstract available


    Clin Epigenetics

  12. FEBER A, Dhami P, Dong L, de Winter P, et al
    UroMark-a urinary biomarker assay for the detection of bladder cancer.
    Clin Epigenetics. 2017;9:8.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  13. KANG M, Balpukov UJ, Jeong CW, Kwak C, et al
    Can the Preoperative Neutrophil-to-Lymphocyte Ratio Significantly Predict the Conditional Survival Probability in Muscle-invasive Bladder Cancer Patients Undergoing Radical Cystectomy?
    Clin Genitourin Cancer. 2017 Jan 9. pii: S1558-7673(16)30324.
    PubMed     Text format     Abstract available


    Clin Lab

  14. YANG D, Huo Q, Luan T, Wang J, et al
    Effects of Angiotensin Inhibitor Valsartan on the Expression of the Angiotensin II 1 Receptor, Matrix Metalloproteinases -2 and -9 in Human Bladder Cancer Cell Lines.
    Clin Lab. 2016;62:1435-1442.
    PubMed     Text format     Abstract available

  15. XU WJ, Wen LP, Jiang XX, Ye LY, et al
    Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Clin Lab. 2017;63:287-293.
    PubMed     Text format     Abstract available


    Cureus

  16. PIRZADA MT, Ghauri R, Ahmed MJ, Shah MF, et al
    Outcomes of BCG Induction in High-Risk Non-Muscle-Invasive Bladder Cancer Patients (NMIBC): A Retrospective Cohort Study.
    Cureus. 2017;9:e957.
    PubMed     Text format     Abstract available


    Diagn Cytopathol

  17. LIN DM, Park JW, Gattuso P
    Metastatic Signet-Ring Cell Carcinoma of the Bladder in Cerebrospinal Fluid.
    Diagn Cytopathol. 2017;45:73-76.
    PubMed     Text format     Abstract available

  18. STROJAN FLEZAR M, Srebotnik-Kirbis I, Gutnik H
    Use of vimentin immunocytochemical staining for evaluation of atypical cells in voided urine samples.
    Diagn Cytopathol. 2017;45:85-90.
    PubMed     Text format     Abstract available


    Diagn Microbiol Infect Dis

  19. GONZALEZ-DEL VECCHIO M, Ruiz-Serrano MJ, Gijon P, Sanchez-Somolinos M, et al
    Differences between a probable and proven BCG infection following intravesical instillations: 16 years experience in a tertiary care hospital.
    Diagn Microbiol Infect Dis. 2016;85:338-43.
    PubMed     Text format     Abstract available


    Drug Dev Res

  20. SHIN SS, Won SY, Noh DH, Hwang B, et al
    Morin Inhibits Proliferation, Migration, and Invasion of Bladder Cancer EJ Cells via Modulation of Signaling Pathways, Cell Cycle Regulators, and Transcription Factor-Mediated MMP-9 Expression.
    Drug Dev Res. 2017 Feb 8. doi: 10.1002/ddr.21377.
    PubMed     Text format     Abstract available


    Eur Radiol

  21. LEE M, Shin SJ, Oh YT, Jung DC, et al
    Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion.
    Eur Radiol. 2017 Feb 6. doi: 10.1007/s00330-017-4759.
    PubMed     Text format     Abstract available

  22. PANEBIANCO V, De Berardinis E, Barchetti G, Simone G, et al
    An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer.
    Eur Radiol. 2017 Feb 8. doi: 10.1007/s00330-017-4758.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  23. THONG AE, Petruzella S, Orlow I, Zabor EC, et al
    Accuracy of Self-reported Smoking Exposure Among Bladder Cancer Patients Undergoing Surveillance at a Tertiary Referral Center.
    Eur Urol Focus. 2016;2:441-444.
    PubMed     Text format     Abstract available


    Front Physiol

  24. WENG H, Zeng XT, Li S, Kwong JS, et al
    Tea Consumption and Risk of Bladder Cancer: A Dose-Response Meta-Analysis.
    Front Physiol. 2017;7:693.
    PubMed     Text format     Abstract available


    G Chir

  25. ALBERTI C
    Urology pertinent neuroendocrine tumors: focusing on renal pelvis, bladder, prostate located sympathetic functional paragangliomas.
    G Chir. 2016;37:55-60.
    PubMed     Text format     Abstract available


    Int J Mol Sci

  26. KANG M, Lee KH, Lee HS, Jeong CW, et al
    Concurrent Autophagy Inhibition Overcomes the Resistance of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Human Bladder Cancer Cells.
    Int J Mol Sci. 2017;18.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  27. SCHUBERT M, Junker K, Heinzelmann J
    Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    J Cancer Res Clin Oncol. 2016;142:1673-95.
    PubMed     Text format     Abstract available


    J Surg Oncol

  28. LI WM, Wei YC, Huang CN, Ke HL, et al
    Matrix metalloproteinase-11 as a marker of metastasis and predictor of poor survival in urothelial carcinomas.
    J Surg Oncol. 2016;113:700-7.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  29. KONG YG, Kim JY, Yu J, Lim J, et al
    Efficacy and Safety of Stroke Volume Variation-Guided Fluid Therapy for Reducing Blood Loss and Transfusion Requirements During Radical Cystectomy: A Randomized Clinical Trial.
    Medicine (Baltimore). 2016;95:e3685.
    PubMed     Text format     Abstract available

  30. XIN J, Lai HP, Lin SK, Zhang QQ, et al
    Bladder leiomyoma presenting as dyspareunia: Case report and literature review.
    Medicine (Baltimore). 2016;95:e3971.
    PubMed     Text format     Abstract available

  31. ZHAO XR, Gao C, Zhang Y, Kong L, et al
    Urachal adenocarcinoma that metastasized to breast was misinterpreted as primary breast mucinous carcinoma: A rare case report and literature review.
    Medicine (Baltimore). 2016;95:e4612.
    PubMed     Text format     Abstract available


    Nurse Pract


  32. Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:33-34.
    PubMed     Text format    

  33. FARLING KB
    Bladder cancer: Risk factors, diagnosis, and management.
    Nurse Pract. 2017;42:26-33.
    PubMed     Text format     Abstract available


    Oncotarget

  34. YANG Y, Li C, Li H, Wu M, et al
    Differential sensitivities of bladder cancer cell lines to resveratol are unrelated to its metabolic profile.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15041.
    PubMed     Text format     Abstract available

  35. ZHOU Y, Song R, Ma C, Zhou L, et al
    Discovery and validation of potential urinary biomarkers for bladder cancer diagnosis using a pseudotargeted GC-MS metabolomics method.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14988.
    PubMed     Text format     Abstract available

  36. DONG Q, Fu L, Zhao Y, Tan S, et al
    Derlin-1 overexpression confers poor prognosis in muscle invasive bladder cancer and contributes to chemoresistance and invasion through PI3K/AKT and ERK/MMP signaling.
    Oncotarget. 2017 Feb 2. doi: 10.18632/oncotarget.15001.
    PubMed     Text format     Abstract available

  37. CHEN M, Li J, Zhuang C, Cai Z, et al
    Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
    Oncotarget. 2017 Feb 1. doi: 10.18632/oncotarget.14945.
    PubMed     Text format     Abstract available


    Radiol Clin North Am

  38. RAMAN SP, Fishman EK
    Upper and Lower Tract Urothelial Imaging Using Computed Tomography Urography.
    Radiol Clin North Am. 2017;55:225-241.
    PubMed     Text format     Abstract available


    Transl Oncol

  39. OLKHOV-MITSEL E, Savio AJ, Kron KJ, Pethe VV, et al
    Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.
    Transl Oncol. 2017;10:168-177.
    PubMed     Text format     Abstract available


    Tumour Biol

  40. STEINESTEL K, Eder S, Ehinger K, Schneider J, et al
    The small conductance calcium-activated potassium channel 3 (SK3) is a molecular target for Edelfosine to reduce the invasive potential of urothelial carcinoma cells.
    Tumour Biol. 2016;37:6275-83.
    PubMed     Text format     Abstract available

  41. WENG WC, Huang YH, Yang SF, Wang SS, et al
    Effect of CD44 gene polymorphisms on risk of transitional cell carcinoma of the urinary bladder in Taiwan.
    Tumour Biol. 2016;37:6971-7.
    PubMed     Text format     Abstract available


    Urologia

  42. MANIKANDAN R, Rodriguez O, Parada R, Palou Redorta J, et al
    Nonmuscle-invasive bladder cancer: what's changing and what has changed.
    Urologia. 2017;84:1-8.
    PubMed     Text format     Abstract available


    Urology

  43. ROBINS DJ, Sui W, Matulay JT, Ghandour R, et al
    Long-Term Survival Outcomes with Intravesical Nanoparticle Albumin-Bound Paclitaxel for Recurrent Nonmuscle Invasive Bladder Cancer after Previous Bacillus Calmette-Guerin Therapy.
    Urology. 2017 Feb 2. pii: S0090-4295(17)30046.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: